(Q41267876)

28 September 2017

1 reference

title

Theophylline in chronic asthma--evidence for disease-modifying properties (English)

1 reference

28 September 2017

Chung KF

1

1 reference

28 September 2017

publication date

1 March 1996

1 reference

Clinical & Experimental Allergy

28 September 2017

published in

1 reference

28 September 2017

volume

26 Suppl 2

1 reference

28 September 2017

page(s)

22-27

1 reference

Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline A “State of the Art” Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Mucosal inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Oxygen radicals produce airway constriction and hyperresponsiveness in anesthetized cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Effect of theophylline and adenosine on eosinophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Model of bronchial allergic inflammation in the brown Norway rat. Pharmacological modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Tumor Necrosis Factor Causes Bronchial Hyperresponsiveness in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Effect of antiasthma drugs on microvascular leakage in guinea pig airways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

The effect of theophylline and enprofylline on allergen-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

21 January 2018

Late asthmatic responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline does not inhibit allergen-induced increase in airway responsiveness to methacholine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

The pharmacology and therapeutic use of theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline inhibits late asthmatic reactions induced by toluene diisocyanate in sensitised subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

The effect of theophyllamine on T-lymphocyte activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline and the immune response: in vitro and in vivo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Theophylline--an immunomodulatory role in asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Protective effect of antiasthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

Reduced responsiveness of adenylate cyclase in alveolar macrophages from patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1996.TB01139.X

10.1111/J.1365-2222.1996.TB01139.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference